Latest News
-
JPMorgan CEO Jamie Dimon Hails PM Modi's Economic Reforms, Urges US to Follow Suit; Details -
Rs. 60/Share Dividend: Record Date On 28 June; Buy The Bajaj Group Stock For 600% Payout? -
Intraday Trade Call: Day Trading Stock Picks By Chandan Taparia Of Motilal Oswal On Thurday, 25 April -
Trade Setup: Nifty Continues Winning Streak Ahead of April F&O Expiry, Q4 Earnings In Focus -
Rs 10/Share Dividend: Record Date In Due Course; Buy The Banking Stock To Be Eligible? -
Stock Market Live Updates: Market Opens Lower; Nifty Dips Below 22,350, Sensex Sheds Over 200 Points -
Tech Mahindra Q4 Results Preview: Revenue May Fall, But Margins Seen To Expand; To Announce Dividend -
Rs. 7.75/Share Dividend: Record Date In Due Course; Buy The TATA Group Stock? -
Trade Call: Day Trading Stock Picks By Sumeet Bagadia of Choice Broking On Thursday, 25th April -
Swing Trading Guide: 3 Stock Picks By VLA Ambala On Thursday, 25th April
List of Indian Pharma Companies Producing Covid-19 Vaccines
Several Indian pharmaceutical firms are working on a coronavirus vaccine as part of global efforts to find a preventive to stem the spread of the deadly virus. Vaccines usually take years to develop and much longer to mass-produce, but scientists are hoping to have one ready in few months. As the number of coronavirus cases in the country continues to increase, the emphasis has shifted to vaccination. The Government of India is leading the fight against the COVID19 pandemic in partnership with the States and UTs. Vaccination is an important part of the Government of India's five-point plan for containing and managing the COVID19 pandemic, which also includes Test, Track, Treat, and COVID Appropriate Behaviour.
As of Monday morning, India had administered over 16.54 crore doses of the COVID-19 vaccine. However, in the midst of the outcry over vaccine shortages, and how many COVID-19 vaccines can these companies produce, and when will India be vaccinated is a big question.
List of Indian Pharma Companies Producing Covid 19 Vaccines:
| Pharma company | Name of Vaccine |
|---|---|
| SII | Covishield |
| Bharat Biotech | Covaxin |
| Biological E | Biological E |
| Zydus Cadila | ZyCoV-D |
| Hetero Biopharma | Sputinik V |
| Dr. Reddy's Laboratories | Sputnik V |
| Panacea Biotech | Covaxin |
| Gennova | HGCO19 |
| Mynvax | Mynvax |
| Hester Biosciences | - |
| Indian Immunologicals | - |
Poonawalla of SII had requested a government grant of Rs 3,000 crore to increase Covishield output beyond 100 million doses per month, which SII expects to meet by the end of May.
Biological E, Gennova, and SII have approached the Department of Biotechnology for help in accessing the Rs 900-crore Covid Suraksha fund set up by the Central government to speed up their vaccine growth.
Zydus Cadila's ZyCov-D, based in Ahmedabad, is one of the COVID-19 vaccines in phase 3 trials.
Biological E, based in Hyderabad, has agreed to produce 60 crore doses of Johnson & Johnson's COVID-19 vaccine per year under a contract manufacturing agreement.
Intranasal COVID-19 vaccine trials are also being conducted by Bharat Biotech.
Some companies are ready to launch their product, while others are either in the testing process or waiting for approval. We'll have to wait until they're available on the market. Covishield and Covaxin are currently available on the Indian market.
GoodReturns.in
